U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.
Shares of EQT Corporation (NYSE:EQT) fell sharply during Monday's session after the company announced that it entered into a definitive merger agreement to acquire Equitrans Midstream.
EQT shares fell 8.4% to $34.37 on Monday.
Here are some other big stocks recording losses in today's session.
Ventyx Biosciences, Inc. (NASDAQ:VTYX) shares tumbled 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.
MoneyLion Inc. (NYSE:ML) dipped 15% to $63.36.
Genie Energy Ltd. (NYSE:GNE) declined 12% to $16.67 following fourth-quarter results.
Nanobiotix S.A. (NASDAQ:NBTX) dipped 9.8% to $6.35.
Pagaya Technologies Ltd. (NASDAQ:PGY) fell 9.6% to $16.54.
Bitfarms Ltd. (NASDAQ:BITF) fell 9% to $2.4290. Bitfarms purchased additional miners to reach 21 EH/s in 2024.
Quantum-Si incorporated (NASDAQ:QSI) declined 9% to $2.03.
Super Micro Computer, Inc. (NASDAQ:SMCI) dipped 8.8% to $1,039.60.
MannKind Corporation (NASDAQ:MNKD) dipped 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.
Applied Therapeutics, Inc. (NASDAQ:APLT) fell 8.4% to $6.35.
Poseida Therapeutics, Inc. (NASDAQ:PSTX) declined 8.1% to $3.74.
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) fell 7.6% to $30.90. Arrowhead Pharmaceuticals recently announced that it initiated its Phase 1/2a study of ARO-DM1 for the treatment of type 1 myotonic dystrophy.
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) dipped 7.6% to $10.31. Arcutis promoted Todd Tucker to Chief Human Resources Officer.
Carvana Co. (NYSE:CVNA) fell 6.3% to $79.96.
Celestica Inc. (NYSE:CLS) fell 5.7% to $43.45. Cormark Securities analyst Jesse Pytlak initiated coverage on Celestica with a Buy rating and announced a price target of $56.
NOVONIX Limited (NYSE:NVX) fell 5.2% to $2.37.
美國股市走低，道瓊斯指數週一下跌超過150點。
殷拓公司（紐約證券交易所代碼：EQT）的股價在週一的交易中大幅下跌，此前該公司宣佈簽訂了收購Equitrans Midstream的最終合併協議。
週一，殷拓股價下跌8.4％，至34.37美元。
以下是今天交易日其他一些錄得跌幅的大型股票。
Ventyx Biosciences, Inc.（納斯達克股票代碼：VTYX）股價下跌18.5％，至8.09美元。Ventyx Biosciences報告了其 NLRP3 抑制劑產品組合的臨床數據，並在虛擬投資者活動上發佈了產品線最新情況。
MoneyLion Inc.（紐約證券交易所代碼：ML）下跌15％，至63.36美元。
吉尼能源有限公司（紐約證券交易所代碼：GNE）公佈第四季度業績後下跌12％，至16.67美元。
Nanobiotix S.A.（納斯達克股票代碼：NBTX）下跌9.8％，至6.35美元。
帕加亞科技有限公司（納斯達克股票代碼：PGY）下跌9.6％，至16.54美元。
比特農場有限公司（納斯達克股票代碼：BITF）下跌9％，至2.4290美元。Bitfarms 購買了更多礦機，以在 2024 年達到 21 EH/s。
量子硅公司（納斯達克股票代碼：QSI）下跌9％，至2.03美元。
超級微電腦公司（納斯達克股票代碼：SMCI）下跌8.8％，至1,039.60美元。
曼肯德公司（納斯達克股票代碼：MNKD）下跌8.7％，至4.81美元。MannKind 公佈了來自 INHALE-3 第 4 期美國試驗的初步膳食挑戰數據，比較了 afrezza 與每日多次注射和胰島素泵的正面交鋒。
應用療法公司（納斯達克股票代碼：APLT）下跌8.4％，至6.35美元。
波塞達治療公司（納斯達克股票代碼：PSTX）下跌8.1％，至3.74美元。
Arrowhead Pharmicals, Inc.（納斯達克股票代碼：ARWR）下跌7.6％，至30.90美元。Arrowhead Pharmicals最近宣佈，它啓動了用於治療 1 型肌強直性營養不良症的 ARO-DM1 的 1/2a 期研究。
Arcutis Biotherapeutics, Inc.（納斯達克股票代碼：ARQT）下跌7.6％，至10.31美元。阿庫蒂斯將託德·塔克晉升爲首席人力資源官。
Carvana Co.紐約證券交易所代碼：CVNA）下跌6.3％，至79.96美元。
Celestica Inc.（紐約證券交易所代碼：CLS）下跌5.7％，至43.45美元。Cormark Securities分析師傑西·皮特拉克以買入評級啓動了對Celestica的報道，並宣佈目標股價爲56美元。
NOVONIX Limited（紐約證券交易所代碼：NVX）下跌5.2％，至2.37美元。
